Evidence map›Paper›PMID 38139277›Full record

ArticleInternational journal of molecular sciences2023

MiR-221-3p/222-3p Cluster Expression in Human Adipose Tissue Is Related to Obesity and Type 2 Diabetes.

Adriana-Mariel Gentile, Said Lhamyani, María Mengual-Mesa, Eduardo García-Fuentes, Francisco-Javier Bermúdez-Silva, Gemma Rojo-Martínez, Mercedes Clemente-Postigo, Alberto Rodriguez-Cañete, Gabriel Olveira, Rajaa El Bekay

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Purslane (Preventive nutrition and food science · 2026
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Adriana-Mariel GentileInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29580 Málaga, Spain.ORCID 0000-0002-2296-9117
Said LhamyaniInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29580 Málaga, Spain.ORCID 0000-0002-9830-9772
María Mengual-MesaAndalucía Tech, Faculty of Health Sciences, Department of Systems and Automation Engineering, School of Industrial Engineering, Universidad de Málaga, Teatinos Campus, 29071 Málaga, Spain.
Eduardo García-FuentesInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29580 Málaga, Spain.ORCID 0000-0002-3491-2724
Francisco-Javier Bermúdez-SilvaInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29580 Málaga, Spain.ORCID 0000-0003-3133-9691
Gemma Rojo-MartínezInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29580 Málaga, Spain.ORCID 0000-0003-2179-2134
Mercedes Clemente-PostigoDepartment of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, 29010 Málaga, Spain.
Alberto Rodriguez-CañeteUnidad de Gestión Clínica de Cirugía General, Digestiva y Trasplantes, Hospital Regional Universitario de Málaga, 29010 Málaga, Spain.
Gabriel OlveiraInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29580 Málaga, Spain.ORCID 0000-0002-7646-2899
Rajaa El BekayInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29580 Málaga, Spain.ORCID 0000-0003-3332-3431
Instituto de Salud Carlos III · ESHospital Regional Universitario de Málaga · ESAndalusian Centre for Nanomedicine and Biotechnology · ESUniversidad de Málaga · ES

Funding

contract from the 'Nicolas Monardes' program from the Servicio Andaluz de Salud, Consejería de Salud y Consumo-Junta de Andalucía C-0030-2016contract from the 'Nicolas Monardes' program from the Servicio Andaluz de Salud, Consejería de Salud y Consumo-Junta de Andalucía RC-0005-2016ISCIII and cofunded by the European Union PI18/00785Plan Andaluz de Investigación, Desarrollo e Innovación post-doctoral grant from the Consejería de Economía, Conocimiento, Empresas y Universidades DOC-01138Plan Propio de Investigación, Transferencia y Divulgación Científica postdoctoral grant from University of Málagathe Consejería de Transformación Económica, Industria, Conocimiento y Universidades-Junta de Andalucía and ERDF-EU PI20-01274the ISCIII and cofunded by the European Union PI21/01924
6 · The paper itself

Abstract

The progression of obesity and type 2 diabetes (T2D) is intricately linked with adipose tissue (AT) angiogenesis. Despite an established network of microRNAs (miRNAs) regulating AT function, the specific role of angiogenic miRNAs remains less understood. The miR-221/222 cluster has recently emerged as being associated with antiangiogenic activity. However, no studies have explored its role in human AT amidst the concurrent development of obesity and T2D. Therefore, this study aims to investigate the association between the miR-221-3p/222-3p cluster in human AT and its regulatory network with obesity and T2D. MiR-221-3p/222-3p and their target gene (TG) expression levels were quantified through qPCR in visceral (VAT) and subcutaneous (SAT) AT from patients (

Indexed as

Diabetes Mellitus, Type 2MicroRNAsAdipose TissueHumansObesityMicroRNAsMIR221, humanhuman adipose tissuemiR-221-3pmiR-221-3p/222-3p clustermiR-222-3pobesitytype 2 diabetes

Identifiers

PMID38139277
PMCPMC10744326
OpenAlexW4389670172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.